First Derivatives CEO Brian Conlon diagnosed with cancer
FD Technologies Public Limited Company
1,792.00p
15:45 15/11/24
0.11%
2.00p
First Derivatives announced on Friday that its chief executive officer Brian Conlon has recently been diagnosed with cancer.
FTSE AIM 100
3,528.04
15:45 15/11/24
n/a
n/a
FTSE AIM 50
3,958.88
15:45 15/11/24
n/a
n/a
FTSE AIM All-Share
728.67
15:45 15/11/24
n/a
n/a
Software & Computer Services
2,469.20
15:44 15/11/24
-0.65%
-16.26
The AIM-traded firm said Conlon would remain at his post during his ongoing weekly treatment, which included chemotherapy.
It said the treatment was expected to last a number of months.
“The board has set a clear strategy and the executive committee, led by Brian, has delivered strong execution of that strategy year-on-year,” said First Derivatives chairman Seamus Keating.
“During the period of his treatment I will provide additional executive and governance support and I am confident that Brian and his team will continue to execute the group's growth plans successfully.”